Cristin Rothfuss

CIK: 0002046214

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)12 (75.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SRPT

Sarepta Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (16 total)

SRPT
Sarepta Therapeutics, Inc.
Sep 4, 2026
Tax Payment(F)
Direct
22K shares at avg. $22.22$489K
SRPT
Sarepta Therapeutics, Inc.
Mar 11, 2026
Tax Payment(F)
Direct
974 shares at avg. $17.03$17K
SRPT
Sarepta Therapeutics, Inc.
Mar 9, 2026
Tax Payment(F)
Direct
346 shares at avg. $16.95$6K
SRPT
Sarepta Therapeutics, Inc.
Mar 9, 2026
Tax Payment(F)
Direct
484 shares at avg. $16.95$8K
SRPT
Sarepta Therapeutics, Inc.
Mar 2, 2026
Tax Payment(F)
Direct
408 shares at avg. $16.20$7K
SRPT
Sarepta Therapeutics, Inc.
Nov 28, 2025
Tax Payment(F)
Direct
229 shares at avg. $21.12$5K
SRPT
Sarepta Therapeutics, Inc.
Sep 3, 2025
Award(A)
Direct
25K shares-
SRPT
Sarepta Therapeutics, Inc.
Sep 3, 2025
Award(A)
Direct
93.9K shares-
SRPT
Sarepta Therapeutics, Inc.
Mar 10, 2025
Award(A)
Direct
8.3K shares-
SRPT
Sarepta Therapeutics, Inc.
Mar 10, 2025
Tax Payment(F)
Direct
491 shares at avg. $100.13$49K
SRPT
Sarepta Therapeutics, Inc.
Mar 7, 2025
Tax Payment(F)
Direct
1.1K shares at avg. $103.70$117K
SRPT
Sarepta Therapeutics, Inc.
Mar 7, 2025
Tax Payment(F)
Direct
347 shares at avg. $103.70$36K
SRPT
Sarepta Therapeutics, Inc.
Mar 4, 2025
Tax Payment(F)
Direct
288 shares at avg. $101.34$29K
SRPT
Sarepta Therapeutics, Inc.
Mar 4, 2025
Tax Payment(F)
Direct
296 shares at avg. $101.34$30K
SRPT
Sarepta Therapeutics, Inc.
Mar 3, 2025
Tax Payment(F)
Direct
391 shares at avg. $103.77$41K
SRPT
Sarepta Therapeutics, Inc.
Nov 26, 2024
Award(A)
Direct
2K shares-

		Type	Shares	Price		Ownership
Sep 4, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	22,025	$22.22	$489,396	Direct
Mar 11, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	974	$17.03	$16,587	Direct
Mar 9, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	346	$16.95	$5,865	Direct
Mar 9, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	484	$16.95	$8,204	Direct
Mar 2, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	408	$16.20	$6,610	Direct
Nov 28, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	229	$21.12	$4,836	Direct
Sep 3, 2025	SRPT Sarepta Therapeutics, Inc.	Award(A)	25,000	-	-	Direct
Sep 3, 2025	SRPT Sarepta Therapeutics, Inc.	Award(A)	93,875	-	-	Direct
Mar 10, 2025	SRPT Sarepta Therapeutics, Inc.	Award(A)	8,276	-	-	Direct
Mar 10, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	491	$100.13	$49,164	Direct
Mar 7, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	1,131	$103.70	$117,285	Direct
Mar 7, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	347	$103.70	$35,984	Direct
Mar 4, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	288	$101.34	$29,186	Direct
Mar 4, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	296	$101.34	$29,997	Direct
Mar 3, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	391	$103.77	$40,574	Direct
Nov 26, 2024	SRPT Sarepta Therapeutics, Inc.	Award(A)	2,000	-	$0	Direct

1-16 of 16 transactions

About Rothfuss Cristin

Rothfuss Cristin (SEC CIK 0002046214) files insider reports with the SEC as EVP, General Counsel of Sarepta Therapeutics, Inc. (SRPT).

Signal8 holds 12 ownership filings by Rothfuss Cristin (1 Form 3, 11 Form 4), filed between Nov 29, 2024 and Sep 8, 2026. Those filings report 16 transactions, from Nov 26, 2024 to Sep 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rothfuss Cristin's filings is in CAMBRIDGE, MA.

Recent filings by Rothfuss Cristin

Sep 4, 2026: Tax withholding of SRPT shares (Form 4, code F).
Mar 11, 2026: Tax withholding of SRPT shares (Form 4, code F).
Mar 9, 2026: Tax withholdings of SRPT shares (2 lines, Form 4, code F).
Mar 2, 2026: Tax withholding of SRPT shares (Form 4, code F).
Nov 28, 2025: Tax withholding of SRPT shares (Form 4, code F).

Other insiders filing for Sarepta Therapeutics, Inc. (SRPT)

Wong Ryan Ho-Yan, Chief Financial Officer
Estepan Ian Michael, Chief Operating Officer
Rodino-Klapac Louise, President, R&D and Tech Ops
SEVERINO MICHAEL, Chief Executive Officer
Boor Kathryn Jean, Director
Mayo Stephen, Director

How to read Form 4 transaction codes